Denosumab Market, Global Outlook and Forecast 2024-2031

Report ID: 1658307 | Published Date: Jan 2025 | No. of Page: 65 | Base Year: 2024 | Rating: 4.1 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Introduction to Research & Analysis Reports
    1.1 Denosumab Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Denosumab Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Denosumab Overall Market Size
    2.1 Global Denosumab Market Size: 2021 VS 2028
    2.2 Global Denosumab Market Size, Prospects & Forecasts: 2017-2028
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Denosumab Players in Global Market
    3.2 Top Global Denosumab Companies Ranked by Revenue
    3.3 Global Denosumab Revenue by Companies
    3.4 Top 3 and Top 5 Denosumab Companies in Global Market, by Revenue in 2021
    3.5 Global Companies Denosumab Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Denosumab Players in Global Market
        3.6.1 List of Global Tier 1 Denosumab Companies
        3.6.2 List of Global Tier 2 and Tier 3 Denosumab Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 by Type - Global Denosumab Market Size Markets, 2021 & 2028
        4.1.2 60 mg
        4.1.3 120 mg
    4.2 By Type - Global Denosumab Revenue & Forecasts
        4.2.1 By Type - Global Denosumab Revenue, 2017-2022
        4.2.2 By Type - Global Denosumab Revenue, 2023-2028
        4.2.3 By Type - Global Denosumab Revenue Market Share, 2017-2028
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Denosumab Market Size, 2021 & 2028
        5.1.2 Hospital
        5.1.3 Clinic
        5.1.4 Others
    5.2 By Application - Global Denosumab Revenue & Forecasts
        5.2.1 By Application - Global Denosumab Revenue, 2017-2022
        5.2.2 By Application - Global Denosumab Revenue, 2023-2028
        5.2.3 By Application - Global Denosumab Revenue Market Share, 2017-2028
6 Sights by Region
    6.1 By Region - Global Denosumab Market Size, 2021 & 2028
    6.2 By Region - Global Denosumab Revenue & Forecasts
        6.2.1 By Region - Global Denosumab Revenue, 2017-2022
        6.2.2 By Region - Global Denosumab Revenue, 2023-2028
        6.2.3 By Region - Global Denosumab Revenue Market Share, 2017-2028
    6.3 North America
        6.3.1 By Country - North America Denosumab Revenue, 2017-2028
        6.3.2 US Denosumab Market Size, 2017-2028
        6.3.3 Canada Denosumab Market Size, 2017-2028
        6.3.4 Mexico Denosumab Market Size, 2017-2028
    6.4 Europe
        6.4.1 By Country - Europe Denosumab Revenue, 2017-2028
        6.4.2 Germany Denosumab Market Size, 2017-2028
        6.4.3 France Denosumab Market Size, 2017-2028
        6.4.4 U.K. Denosumab Market Size, 2017-2028
        6.4.5 Italy Denosumab Market Size, 2017-2028
        6.4.6 Russia Denosumab Market Size, 2017-2028
        6.4.7 Nordic Countries Denosumab Market Size, 2017-2028
        6.4.8 Benelux Denosumab Market Size, 2017-2028
    6.5 Asia
        6.5.1 By Region - Asia Denosumab Revenue, 2017-2028
        6.5.2 China Denosumab Market Size, 2017-2028
        6.5.3 Japan Denosumab Market Size, 2017-2028
        6.5.4 South Korea Denosumab Market Size, 2017-2028
        6.5.5 Southeast Asia Denosumab Market Size, 2017-2028
        6.5.6 India Denosumab Market Size, 2017-2028
    6.6 South America
        6.6.1 By Country - South America Denosumab Revenue, 2017-2028
        6.6.2 Brazil Denosumab Market Size, 2017-2028
        6.6.3 Argentina Denosumab Market Size, 2017-2028
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Denosumab Revenue, 2017-2028
        6.7.2 Turkey Denosumab Market Size, 2017-2028
        6.7.3 Israel Denosumab Market Size, 2017-2028
        6.7.4 Saudi Arabia Denosumab Market Size, 2017-2028
        6.7.5 UAE Denosumab Market Size, 2017-2028
7 Players Profiles
    7.1 Amgen
        7.1.1 Amgen Corporate Summary
        7.1.2 Amgen Business Overview
        7.1.3 Amgen Denosumab Major Product Offerings
        7.1.4 Amgen Denosumab Revenue in Global Market (2017-2022)
        7.1.5 Amgen Key News
    7.2 Qilu Pharmaceutical
        7.2.1 Qilu Pharmaceutical Corporate Summary
        7.2.2 Qilu Pharmaceutical Business Overview
        7.2.3 Qilu Pharmaceutical Denosumab Major Product Offerings
        7.2.4 Qilu Pharmaceutical Denosumab Revenue in Global Market (2017-2022)
        7.2.5 Qilu Pharmaceutical Key News
    7.3 Shandong Boan Biotech
        7.3.1 Shandong Boan Biotech Corporate Summary
        7.3.2 Shandong Boan Biotech Business Overview
        7.3.3 Shandong Boan Biotech Denosumab Major Product Offerings
        7.3.4 Shandong Boan Biotech Denosumab Revenue in Global Market (2017-2022)
        7.3.5 Shandong Boan Biotech Key News
    7.4 Shanghai Mabwell
        7.4.1 Shanghai Mabwell Corporate Summary
        7.4.2 Shanghai Mabwell Business Overview
        7.4.3 Shanghai Mabwell Denosumab Major Product Offerings
        7.4.4 Shanghai Mabwell Denosumab Revenue in Global Market (2017-2022)
        7.4.5 Shanghai Mabwell Key News
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer

List of Tables
    Table 1. Denosumab Market Opportunities & Trends in Global Market
    Table 2. Denosumab Market Drivers in Global Market
    Table 3. Denosumab Market Restraints in Global Market
    Table 4. Key Players of Denosumab in Global Market
    Table 5. Top Denosumab Players in Global Market, Ranking by Revenue (2021)
    Table 6. Global Denosumab Revenue by Companies, (US$, Mn), 2017-2022
    Table 7. Global Denosumab Revenue Share by Companies, 2017-2022
    Table 8. Global Companies Denosumab Product Type
    Table 9. List of Global Tier 1 Denosumab Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 10. List of Global Tier 2 and Tier 3 Denosumab Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 11. By Type – Global Denosumab Revenue, (US$, Mn), 2021 & 2028
    Table 12. By Type - Denosumab Revenue in Global (US$, Mn), 2017-2022
    Table 13. By Type - Denosumab Revenue in Global (US$, Mn), 2023-2028
    Table 14. By Application – Global Denosumab Revenue, (US$, Mn), 2021 & 2028
    Table 15. By Application - Denosumab Revenue in Global (US$, Mn), 2017-2022
    Table 16. By Application - Denosumab Revenue in Global (US$, Mn), 2023-2028
    Table 17. By Region – Global Denosumab Revenue, (US$, Mn), 2021 & 2028
    Table 18. By Region - Global Denosumab Revenue (US$, Mn), 2017-2022
    Table 19. By Region - Global Denosumab Revenue (US$, Mn), 2023-2028
    Table 20. By Country - North America Denosumab Revenue, (US$, Mn), 2017-2022
    Table 21. By Country - North America Denosumab Revenue, (US$, Mn), 2023-2028
    Table 22. By Country - Europe Denosumab Revenue, (US$, Mn), 2017-2022
    Table 23. By Country - Europe Denosumab Revenue, (US$, Mn), 2023-2028
    Table 24. By Region - Asia Denosumab Revenue, (US$, Mn), 2017-2022
    Table 25. By Region - Asia Denosumab Revenue, (US$, Mn), 2023-2028
    Table 26. By Country - South America Denosumab Revenue, (US$, Mn), 2017-2022
    Table 27. By Country - South America Denosumab Revenue, (US$, Mn), 2023-2028
    Table 28. By Country - Middle East & Africa Denosumab Revenue, (US$, Mn), 2017-2022
    Table 29. By Country - Middle East & Africa Denosumab Revenue, (US$, Mn), 2023-2028
    Table 30. Amgen Corporate Summary
    Table 31. Amgen Denosumab Product Offerings
    Table 32. Amgen Denosumab Revenue (US$, Mn), (2017-2022)
    Table 33. Qilu Pharmaceutical Corporate Summary
    Table 34. Qilu Pharmaceutical Denosumab Product Offerings
    Table 35. Qilu Pharmaceutical Denosumab Revenue (US$, Mn), (2017-2022)
    Table 36. Shandong Boan Biotech Corporate Summary
    Table 37. Shandong Boan Biotech Denosumab Product Offerings
    Table 38. Shandong Boan Biotech Denosumab Revenue (US$, Mn), (2017-2022)
    Table 39. Shanghai Mabwell Corporate Summary
    Table 40. Shanghai Mabwell Denosumab Product Offerings
    Table 41. Shanghai Mabwell Denosumab Revenue (US$, Mn), (2017-2022)
List of Figures
    Figure 1. Denosumab Segment by Type in 2021
    Figure 2. Denosumab Segment by Application in 2021
    Figure 3. Global Denosumab Market Overview: 2021
    Figure 4. Key Caveats
    Figure 5. Global Denosumab Market Size: 2021 VS 2028 (US$, Mn)
    Figure 6. Global Denosumab Revenue, 2017-2028 (US$, Mn)
    Figure 7. The Top 3 and 5 Players Market Share by Denosumab Revenue in 2021
    Figure 8. By Type - Global Denosumab Revenue Market Share, 2017-2028
    Figure 9. By Application - Global Denosumab Revenue Market Share, 2017-2028
    Figure 10. By Region - Global Denosumab Revenue Market Share, 2017-2028
    Figure 11. By Country - North America Denosumab Revenue Market Share, 2017-2028
    Figure 12. US Denosumab Revenue, (US$, Mn), 2017-2028
    Figure 13. Canada Denosumab Revenue, (US$, Mn), 2017-2028
    Figure 14. Mexico Denosumab Revenue, (US$, Mn), 2017-2028
    Figure 15. By Country - Europe Denosumab Revenue Market Share, 2017-2028
    Figure 16. Germany Denosumab Revenue, (US$, Mn), 2017-2028
    Figure 17. France Denosumab Revenue, (US$, Mn), 2017-2028
    Figure 18. U.K. Denosumab Revenue, (US$, Mn), 2017-2028
    Figure 19. Italy Denosumab Revenue, (US$, Mn), 2017-2028
    Figure 20. Russia Denosumab Revenue, (US$, Mn), 2017-2028
    Figure 21. Nordic Countries Denosumab Revenue, (US$, Mn), 2017-2028
    Figure 22. Benelux Denosumab Revenue, (US$, Mn), 2017-2028
    Figure 23. By Region - Asia Denosumab Revenue Market Share, 2017-2028
    Figure 24. China Denosumab Revenue, (US$, Mn), 2017-2028
    Figure 25. Japan Denosumab Revenue, (US$, Mn), 2017-2028
    Figure 26. South Korea Denosumab Revenue, (US$, Mn), 2017-2028
    Figure 27. Southeast Asia Denosumab Revenue, (US$, Mn), 2017-2028
    Figure 28. India Denosumab Revenue, (US$, Mn), 2017-2028
    Figure 29. By Country - South America Denosumab Revenue Market Share, 2017-2028
    Figure 30. Brazil Denosumab Revenue, (US$, Mn), 2017-2028
    Figure 31. Argentina Denosumab Revenue, (US$, Mn), 2017-2028
    Figure 32. By Country - Middle East & Africa Denosumab Revenue Market Share, 2017-2028
    Figure 33. Turkey Denosumab Revenue, (US$, Mn), 2017-2028
    Figure 34. Israel Denosumab Revenue, (US$, Mn), 2017-2028
    Figure 35. Saudi Arabia Denosumab Revenue, (US$, Mn), 2017-2028
    Figure 36. UAE Denosumab Revenue, (US$, Mn), 2017-2028
    Figure 37. Amgen Denosumab Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 38. Qilu Pharmaceutical Denosumab Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 39. Shandong Boan Biotech Denosumab Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 40. Shanghai Mabwell Denosumab Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
65
Frequently Asked Questions
Denosumab Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Denosumab Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Denosumab Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports